Page last updated: 2024-09-03

293b cpd and cromakalim

293b cpd has been researched along with cromakalim in 1 studies

Compound Research Comparison

Studies
(293b cpd)
Trials
(293b cpd)
Recent Studies (post-2010)
(293b cpd)
Studies
(cromakalim)
Trials
(cromakalim)
Recent Studies (post-2010) (cromakalim)
1000161,3882079

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BarĂ³, I; Charpentier, F; Escande, D; Kunzelmann, K; Loussouarn, G; Mohammad-Panah, R1

Other Studies

1 other study(ies) available for 293b cpd and cromakalim

ArticleYear
KvLQT1 potassium channel but not IsK is the molecular target for trans-6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethyl- chromane.
    Molecular pharmacology, 1997, Volume: 52, Issue:6

    Topics: Animals; Binding Sites; Chromans; COS Cells; Cromakalim; Kinetics; Long QT Syndrome; Potassium; Potassium Channel Blockers; Potassium Channels; Sulfonamides

1997